Nureca (NURECA)₹302.10−0.72%Medical Equipment & Supplies
At the end of the Sep 2026 quarter, Nureca's shareholders were: promoters 70.69%, FIIs 0.22%, DIIs 0.24%, public 28.85%. Promoter holding is up 2.59 percentage points from 68.10% a quarter earlier. FII holding is up 0.15 percentage points from 0.07% a year earlier. 0.00% of promoter shares were pledged. It had 31,716 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 63.25% | 63.25% | 63.25% | 63.79% | 64.07% | 64.31% | 64.34% | 64.98% | 64.98% | 68.10% | 68.10% | 70.69% |
| FIIs | 0.07% | 0.07% | 0.07% | 0.70% | 0.36% | 1.08% | 0.07% | 0.07% | 0.08% | 0.28% | 0.11% | 0.22% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.04% | 0.04% | 0.04% | 0.04% | 0.04% | 0.24% | 0.24% | 0.24% |
| Public | 36.68% | 36.68% | 36.68% | 35.51% | 35.53% | 34.57% | 35.55% | 34.91% | 34.90% | 31.38% | 31.55% | 28.85% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 49,595 | 45,992 | 43,809 | 41,982 | 41,310 | 39,300 | 38,071 | 37,464 | 35,798 | 34,555 | 33,976 | 31,716 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Saurabh Goyal | Promoter | 70.09% | +35.73 |
| Smita Goyal | Promoter | 0.60% | New |
| Payal Goyal | Promoter | Exited | −21.64 |
| Aryan Goyal | Promoter | Exited | −12.10 |
| Nectar Biopharma Private Limited | Promoter | 0.00% | 0.00 |
Promoters held 70.69% of Nureca at the end of the Sep 2026 quarter, up 5.71 percentage points from 64.98% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 0.22% (up 0.11 percentage points from 0.11% a quarter earlier) and domestic institutions (DIIs) held 0.24% (unchanged at 0.24% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Nureca had 31,716 shareholders at the end of the Sep 2026 quarter, against 37,464 a year earlier.